The term "Monpellerin" comes from The Road to Serfdom, an economic work by British Nobel laureate in Economics Friedrich von Hayek. In July 1947, Hayek founded the Mont Pelerin Society, a neoliberal academic group, in Switzerland. Its origin, Mont Pèlerin located between Lake Geneva and the Alps, boasts breathtakingly magnificent scenery and is a shared sacred site for both pious believers of the Middle Ages and modern hikers .

The founder of Monpellerin is a devout Christian and he chooses "Monpellerin" as the brand name and hopes to convey care to the world via the brand and glorify God. The founder's faith in God shapes the brand's unique essence. Guided by this faith, Monpellerin focuses on customers' healthcare needs and engages in the translational medicine field, with its core philosophy of breaking inherent barriers between basic medicine, drug R&D and clinical medicine to quickly turn scientific achievements into accessible treatments for the public.

Since the U.S. journal Science first introduced the concept of "bench to bedside" in 1992, translational medicine, as an emerging interdisciplinary field, has attracted growing attention from scholars and research institutions worldwide. In China, Monpellerin is a dedicated practitioner of the translational medicine concept. By integrating global clinical resource data, it has built a multi-center clinical big data analysis and application platform. Leveraging its strong scientific research capabilities, it has also developed a series of high-quality healthcare products, bringing the hope of health to millions of families.

As a newly emerging leading brand in China, Monpellerin actively supports the national Outline of the Healthy China 2030 Plan and taking it as the responsibility to provide truely effective treatments for patients, Monpellerin has sealed long-term alliances with hundreds of meidical institutions and labs at home and abroad. It conducts academic exchange, clinical collaboration and R&D innovation to steadly creat healthy products and services covering the whole life cycle from pregnancy and birth, growthup to healthy aging.

Meeting consumers' unmet medical needs through innovative R&D serves as the driving force for Monpellerin's continuous progress. It's firmly believed that in its future journey of self-transformation, Monpellerin will, with a global vision, advance the full-industry-chain strategic layout centered on "translational medicine," enabling consumers to truly enjoy the health